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Abstract 
 A cardiovascular system (CVS) model and parameter identification method have previously been 
validated for identifying different cardiac and circulatory dysfunctions in simulation and using porcine 
models of pulmonary embolism, hypovolemia with PEEP titrations, and induced endotoxic shock. 
However, these studies required both left and right heart catheters to collect the data required for subject-
specific monitoring and diagnosis – a maximally invasive data set in a critical care setting although it does 
occur in practice. Hence, use of this model-based diagnostic would require significant additional invasive 
sensors for some subjects, which is unacceptable in some, if not all, cases. The main goal of this study is 
to prove the concept of using only measurements from one side of the heart (right) in a “minimal” data set 
to identify an effective patient-specific model that can capture key clinical trends in endotoxic shock. 
 
This research extends existing methods to a reduced and minimal data set requiring only a single catheter 
and reducing the risk of infection and other complications – a very common, typical situation in critical care 
patients, particularly after cardiac surgery. The extended methods and assumptions that found it are 
developed and presented in a case study for the patient-specific parameter identification of pig-specific 
parameters in an animal model of induced endotoxic shock. This case study is used to define the impact 
of this minimal data set on the quality and accuracy of the model-application for monitoring, detecting and 
diagnosing septic shock.  
 
Six anesthetized healthy pigs weighing 20-30 kg received a 0.5- mg/kg endotoxin infusion over a period of 
30 mins from T0 to T30. For this research, only right heart measurements were obtained. Errors for the 
identified model are within 8% when the model is identified from data, re-simulated and then compared to 
the experimentally measured data, including measurements not used in the identification process for 
validation. Importantly, all identified parameter trends match physiologically and clinically and 
experimentally expected changes, indicating that no diagnostic power is lost. 
 
This work represents a further with human subjects validation for this model-based approach to 
cardiovascular diagnosis and therapy guidance in monitoring endotoxic disease states. The results and 
methods obtained can be readily extended from this case study to the other animal model results 
presented previously. Overall, these results provide further support for prospective, proof of concept 
clinical testing with humans. 
 
 
Keywords: cardiovascular system, cardiac model, parameter identification, integral method, endotoxin, 
septic shock 
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Introduction 
Sepsis is a very complex and serious systemic response to infection. Sepsis results in as many deaths in 
the USA as out-of-hospital cardiac arrests, and four times the number for breast cancer [1]. More 
specifically, mortality rates have ranged from 25% to 80% over the last few decades [2]. Septic shock or 
severe sepsis and multiple organ failure are thus one of the leading causes for morbidity and mortality in 
the critical care setting. 
 
Septic shock is characterized by a decreased venous return to the right heart caused by the combinatory 
effects of capillary leaks, reduced stressed systemic volume and loss of circulatory tone, leading also to a 
decreased systemic arterial resistance. Moreover, venous capacitance and pulmonary resistance are 
usually increased, which, together with a reduced ventricle contractility, lead to impaired stroke volume 
and cardiac output [3]. A simultaneously decreased systemic arterial resistance therefore leads to a low 
blood pressure and consequently hypotension. Fluid resuscitation can compensate for the capillary leak 
and result in increased venous return. Most patients in septic shock after fluid resuscitation thus have a 
high cardiac output, but a low systemic vascular resistance state [4-6] and by definition all need 
vasopressors to keep mean systemic arterial pressure in normal range.  
 
These points thus clearly indicate the key clinically important diagnostic characteristics and treatments, as 
well as the need to obtain an early diagnostic as soon as the dysfunction begins to occur to provide the 
greatest chance for successful intervention. In addition, it is clearly evident that the primary therapies have 
a feedback effect on the cardiovascular system that can be difficult to predict. Hence, model-based 
methods for patient specific diagnosis of this dysfunction and others have been developed. 
 
In particular, the CVS model and identification process used herein have previously been validated in the 
identification and model-based analysis of induced endotoxic shock with continuous veno-venous 
hemofiltration (CVVH) therapy in a porcine animal model [7]. It has also been applied to similar porcine 
animal model analyses of pulmonary embolism [8]  and mechanical ventilation in ARDS [9, 10]. In this 
research, a porcine model of induced endotoxic shock without hemofiltration is analyzed and the CVS 
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model parameters are identified.  
 
The novelty of this identification is that for the first time the identification process is applied to strictly right 
ventricle signals and no left ventricle signals were measured. This significantly reduced data set is of 
particular clinical importance, as often only limited data, such as data from only one of the ventricles, is 
available. Reducing this data set reduces the number of highly invasive catheters required from an 
unusual in critical care value of two, to a very typical value of one catheter. Hence, it also reduces 
significant added risk of complications and infection that can be associated with these catheters [11]. This 
analysis on the impact of the reduction of invasive catheters is thus critical to establishing the potential 
and initial feasibility of this model-based approach to monitoring and diagnosis of cardiovascular 
dysfunction using experimental animal models of endotoxic shock. 
 
More specifically, the CVS model and identification process are therefore applied here to only the 
measured right ventricle signals under a series of assumptions. However, similar contractility and afterload 
trends are obtained when compared to previously reported experimental results using full data sets for 
both the left and right heart [12]. The overall goal is  to show the robustness of the extended methods 
developed, to define the clinical potential to use this type of minimally invasive, model-based physiological 
monitoring to diagnose clinically important developing disease states.  
  
Methodology 
CVS model 
The CVS model is a lumped parameter model, previously developed by [13, 14] and based on earlier 
simplified  models with less chambers and variables [15, 16]. The new and extended model is presented 
in detail in [9, 10, 17]. Briefly, the new and extended CVS model includes one extra compartment for the 
lung capillaries and a second, extra compartment has been added for the systemic capillaries. This 
change separates the venous and arterial systems and resistances, which is more physiologically 
accurate. Figure 1 shows these modifications with the two new compartments for the systemic and 
pulmonary capillaries. 
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This physiologically relevant addition is of great interest as two resistances on either side, the arterial and 
venous side, are necessary to correctly model/capture the complex behaviors observed clinically during, 
for example, mechanical or spontaneous breathing [10], thus physiologically justifying this model 
extension based on results from an independent clincial scenario and independent set of data.  
 
This new model also more correctly represents the anatomy, where the pulmonary arteries and veins as 
well as the vena cava are within the thoracic cavity. Moreover, neither the aorta, as modelled as part of 
the systemic circulation, nor the lung capillaries, which are surrounded by alveolar pressure, are 
surrounded by intrathoracic pressure (Pth). More details about this new model definition and its clinical and 
physiological relevance are available in [7, 9, 10, 17] and the main equations are recalled in the appendix. 
 
Parameter identification method 
In this research, the main goal is to identify the CVS model parameters based only on measured input 
data from the right side of the heart, using only estimated left ventricle signals. The measured signals for 
this research that are used for identification are the pressures in the aorta and pulmonary artery (Pao, Ppa), 
and the volume in the right ventricle (Vrv). 
 
The complete identification process using a full set of measured data and catheters in both the left and 
right heart, has previously been described [7-10]. Therefore, in this research, only a brief overview is given 
focusing on the specific aspects of performing the identification with the reduced data set. In particular, as 
the left ventricle signals are not measured in this reduced data study, they must be estimated for the 
identification process, which is thus the focus and novelty of this approach presented. 
 
For this study, the left ventricular volume (Vlv) is assumed to be the same as the measured right 
ventricular volume (Vrv) for simplicity. Thus, the left ventricle stroke volume (LVSV) is also assumed to be 
the same as the measured right ventricle stroke volume (RVSV). The left ventricular pressure (Plv) is not 
required during the identification process and is thus not specifically estimated. These approximations are 
6 
 
not necessarily completely accurate in a dynamic, septic patient or animal model thereof, but provide a 
useful, effective and physiologically justified initial starting point. 
 
The waveforms are artificially generated by scaling a set of previously calculated model outputs to best fit 
the measured maximum and minimum data values for the pressures and volumes. The assumption is that 
these model waveforms are reasonably conformable with the actual case seen clinicallly. In addition, it is 
thus assumed that thse signals are representative of the model's ability to capture any similar waveform. 
This approach is similar to others taken in the literature with similarly minimal data sets [18-21]. 
 
These scaled signals are then used in place  of the (now unmeasured in this study) left heart signals in the 
full parameter identification process reported previously. Subsequent to this identificaiton a new CVS 
forward simulation is performed with theses newly identified parameters. The result is a much closer 
match to the experimental data than what was provided by the first initial parameter set. This animal-
specific model simulated output is then compared to the experimental data to assess performance.  
 
In further subsequent iterations, these new model-generated output signals can be re-scaled again, and a 
subsequent (second or higher) set of model parameters identified. The results of this subsequent set of 
parameter identification interations are (as above) used to run a further simulation. This overall iterative 
process is stopped when the relative error between model output and measured experimental data 
reaches a set tolerance or fails to improve. Figure 2 gives an overview of the overall identification process. 
 
Model parameter values are presented as mean normalized values over all analyzed pigs to allow 
comparison between pigs who have very different values for an equivalent physiological state. Previously 
reported values for the same experimental data of induced septic shock [12] are also normalized for 
comparison. Data values are normalized with regard to the baseline (time=0 mins) value for each pig to 
guarantee the correct representation of the parameter trends over all pigs, rather than showing the 
absolute values where extreme low or high values for one pig can easily influence the mean value over all 
pigs. All the data is thus self-normalized before comparison across pigs or treatment method. 
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Volume calculations 
The central venous pressure (CVP) or systemic pressure Psys plays a central role in the CVS model and 
identification process. The CVP provides insight into the venous system function and, more specifically, 
about the effective systemic volume Vsys,eff. However, CVP is not measured in this experiment and there is 
also no directly measured information available about the volume status of the pigs. Therefore, certain 
assumptions about the volumes and pressures in the CVS model have to be made.  
 
These assumptions help guarantee that the best and most optimal parameters, relative to these assumed 
volumes, are identified. In all cases, the identified model parameters are then used to re-simulate the 
model and produce output signals that not only match the measured signals, but also all other estimated 
volumes and pressures. The overall approach thus provides a consistent means of identification and 
method validation, given the limited available experimental data in this study, which is representative of a 
typical clinical scenario. Hence, while specific values for unmeasured (left ventricle) pressures and 
volumes may not be perfect based on these assumptions, the main goal is to ensure key clinical trends of 
the identified model parameters match those expected in experimentallly observed endotoxic shock. 
 
More specifically, it is known that during septic shock the effective systemic volume decreases as a result 
of capillary leak (absolute hypovolemia) or venodilation (relative hypovolemia) [5, 6]. Therefore, the 
evolution of septic shock was simulated in this research by a stepwise reduction of 5% of the effective 
systemic volume Vsys,eff every 30 minutes. This stepwise reduction is a rather conservative estimate of the 
reduction in volume [22]. If necessary, the CVS model can easily be run with more severe reductions 
simulating more severe forms of septic shock. Hence, septic shock may be assessed parametrically in 
clinical or experimental situations by testing the model and identificaiton for such reductions, although that 
is not tested here. Thus, in this study, all initial CVS model volumes are estimated based on the known 
distribution of blood, as previously described in [9, 10]. 
   
Experimental protocol 
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All experimental procedures and protocols used in this investigation were reviewed and approved by the 
Ethics Committee of the Medical Faculty of the University of Liege. The investigation conforms with the 
Guide for the Care and Use of Laboratory Animals published by the US National Institutes of Health (NIH 
Publication No. 85-23, revised 1996). 
 
Experiments were performed on 6 healthy pure pietran pigs of either sex weighing from 20 to 30 kg. The 
animals were premedicated with intramuscular administration of ketamine (20 mg/kg) and diazepam (1 
mg/kg). Anesthesia was then induced and maintained by a continuous infusion of sufentanil (0.5 µg/kg/h) 
and pentobarbital (5 mg/kg/h). Spontaneous movements were prevented by pancuronium bromide (0.2 
mg/kg). After endotracheal intubation through a cervical tracheostomy, the pigs were connected to a 
volume cycled ventilator (Evita 2, Drager, Lubeck, Germany) set to deliver a tidal volume of 10 ml/kg with 
a FiO2 of 0.4 and at a respiratory rate of 20 breaths /min. End-tidal CO2 (PETCO2 ) measurements 
(Capnomac, Datex, Helsinki, Finland) were used to monitor the adequacy of ventilation. Respiratory 
settings were adjusted to maintain PETCO2 between 30 and 35 mmHg. 
 
The animals received a 0.5 mg/kg endotoxin infusion (lipopolysaccharide from Escherichia coli serotype 
0127:B8; Sigma Chemical, St. Louis, MO, U.S.A.) over 30 mins (from T0 to T30) and received no further 
intervention. Measurements were obtained for systemic arterial pressure (Pao), pulmonary arterial 
pressure (Ppa) and right ventricle pressure and volume (Prv, Vrv) as described previously in [12]. 
 
Measurements were obtained every 30 minutes into the experiment, from T0 to T300 minutes. Note, that 
for pig 1, only 4 measurements were obtained (T0 - T90); for pig 2, 9 measurements (T0 - T240); for pig 5, 
8 measurements (T0 - T210) and for pig 6, 7 measurements (T0 - T180). Pigs 3 and 4 had the full amount 
of 11 measurements (T0 - T300), thus totalling 50 measurements over all pigs. 
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Analysis of Results: 
 
The main form of analysis is comparison of errors at each time point in the experiment between the re-
simulated animal specific model and the experimental data, where, as noted, the right ventricular 
pressures were not used in the identification process and provide a unique further form of validation. 
Further, each time point in this experiment is a specific cardiovascular state that is uniquely different from 
the prior one as endotoxic shock progresses. Therefore, comparisons of errors or fitting between time 
points in the progression of endotoxic shock, except as presented in aggregate in Table 1, are less 
relevant as they represent very different physiological states that the model may or may not capture. In 
addition, unavoidable variability in the progression of experimental endotoxic shock will make further 
comparisons even within time periods difficult. What is more important in this proof of concept analysis is 
to determine if the errors are consistent  across all pigs in each specific state to identify if there are 
specific physiological states the model cannot identify good parameters or trends.  
 
Each identified value for all major signals is therefore plotted for each pig at all time points captured for 
that pig, clearly showing the errors for that time point and pig in progression. These plots are 
concatenated to show: a) all 6 pigs and errors on a single plot for clarity; and b) to show the variability in 
physiological signals seen across pigs in each state. Both of these factors would be lost by lumping all 
errors and states together. 
 
Finally, there are very few overall points (N = 59) which, considering 5 major time points and physiological 
states in the experiment with very different values for these identified signals. Hence, obtaining more than 
a central tendency (median and IQR) is not effective to show the shape or distribution that might arise for 
greater numbers. These values are already plotted as noted above. Finally, non-parametric statistics are 
used (median, IQR) due to the relatively uniform (non-Gaussian) distribution of errors around median 
values. 
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Results 
Figure 3 (a)-(c) illustrates the match between experimental data and identified and re-simulated model for 
one specific pig in detail at 0, 90 and 120 minutes. The first subfigure shows the right ventricle signals at 
the beginning of the experiment (T0). The upper panel shows the experimental vs. simulated right 
ventricular pressure and the pressure in pulmonary artery. In the lower panel, the experimental vs. 
simulated right ventricular volume is shown. Importantly, during the identification process only the systolic 
(maximum) and diastolic (minimum) values of the measured ventricle volume (EDV, ESV) and arterial 
pressure (SPAP, DPAP) are used. The right ventricular pressure (Prv) is not used, as this measurement is 
rarely obtained in a typical clinical setting, although it is more common in some research settings and was 
thus measured in this study. Thus, it is important to note that the RV pressures (top plots) in Figures 3 
have very little error, as confirmed in Table 1 for all pigs with median absolute error of 2.87-4.33% for 
systolic and diastolic pressures, even though that measurement was not used in the identification process. 
This “true” validation should further serve to show the capability of the identification process and model.   
 
If desired, the ventricle pressure waveforms between the minimum and maximum values could easily be 
matched more accurately by adjusting the generic activation driver function shapes used in the CVS 
model [13, 14]. However, this level of accuracy and added modification was not intended in this study. 
Additionally, clincal diagnostics are driven primarily by these minimum and maximum values, and their 
range, and not by te specific waveform shape. The following subfigures illustrate the same results and 
level of correlation between model and data at 90 and 120 minutes into the experiment for the same pig 
as in Figure 3. 
 
As noted, it was never intended to perfectly match the pressure and volume waveform shapes, but only 
the minimum and maximum experimentally measurable values, and to thus capture key cliincal trends. 
This goal was adopted because the main focus is to identify the overall macro-hemodynamic condition, 
and less interest is placed on exactly matching the specific waveforms.  
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Table 1 shows the median absolute percentage errors for the identified minimum and maximum pressure 
and volume signals (SAP, DAP, SPAP, DPAP, RVESV, RVEDV, RVSV) for the identified re-simulated 
model over all pigs. It also shows the span of the interquartile range (75th percentile – 25th percentile) as it 
was centered uniformly (non-Gaussian) around the median value in all cases for this analysis. The central 
tendency (median, IQR) of the errors is well below 10%, which is within typical measurement noise levels. 
 
Figure 4 shows the right ventricular stroke volumes (RVSV) for all identified time segments over all pigs. 
The solid line represent the experimental data while the crosses represent the CVS model simulation 
output when re-run using the animal-specific identified model parameters. As can be seen, the model 
output values match the true experimental values very well, with median absolute percentage errors less 
than 5%, which is well within measurement or estimate errors [23, 24]. It can also be seen that there is 
significant inter-pig variation, as might be expected, particularly for pig 2 that has a much higher set of 
values. Hence, this results also shows the model’s ability to capture, in a pig-specific fashion, the 
potentially significant and large variation between subjects that could affect diagnostic accuracy if missed. 
 
Figure 5 shows the systemic arterial systolic and diastolic pressure values (SAP, DAP) over all times and 
pigs. The solid lines represent the experimental measurement and the +, □  markers represent the 
identified animal-specific CVS model output for SAP and DAP respectively. Again, per the values in Table 
1, matches are obtained with median absolute percentage errors less than 3% and minimal IQR (centered 
on the median) range of less than 5%, which are below measurement errors of 10% for the same signals. 
 
Figure 6 shows the pulmonary arterial systolic and diastolic pressure values (SPAP, DPAP) over all times 
and pigs. The solid lines represent the experimental measurement and the +, □  markers represent the 
identified, animal-specific CVS model output for SPAP and DPAP respectively. Matches with similar error 
in Table 1 are obtained, with median absolute percentage errors less than 7%. 
 
Figure 7 (a)-(d) shows the mean normalized systemic stressed volume (Vsys,eff), and the identified mean 
normalized systemic vascular (Rsys) and pulmonary resistance (Rpulin), as well as the resistance to venous 
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return (Rvr) over all pigs during the endotoxic shock experiment. 
 
The upper panel in Figure 8 shows the experimentally measured right ventricular end-systolic elastance 
(Eesrvf) during the endotoxic shock experiment, as previously reported [12]. The lower panel of Figure 8 
shows the similar results obtained from the CVS model and identification process using the limited data 
set available for this study. This elastance, as with other model parameters, is found in the parameter 
idnetification, and its diagnostic valuae is independently assessed using clinical calculations [12]. 
 
Note that the absolute values obtained for Eesrvf depend on the unstressed ventricle volume (Vd). For 
reasons of simplicity, this value is assumed to be zero (Vd=0 ml) during the identification process. 
However, Eesrvf can easily be adjusted for a different, and probably more realistic, Vd, as these adjustments 
have no effect on the other identified model parameters. Overall, the identified Eesrvf trends match well with 
recently reported values obtained for the same experimental data [12], as shown in comparing the upper 
and lower panels of Figure 8. 
  
Discussion 
One of the major goals of this research is to show the applicability of the CVS model and identification 
process to capture key experimentally observed trends over time for a clinically difficulty and important 
scenario using a severely reduced, minimally invasive data set that is clinically typical/relevant. In 
particular, in this research, only the right heart signals (Vrv, Ppa) and the arterial pressure (Pao) are 
available for identifying the induced endotoxic shock. Despite this restricted data set and the additional 
assumptions made regarding the other model volumes and pressures, the CVS model parameters are 
consistently identified. This accurate level of identification is validated by re-simulation and comparison to 
experimental data including measured data not used in the identification process. Importantly, it holds true 
not only for the right part of the model, but for the entire parameter set. 
 
When re-simulating the model with the identified parameters, the output signals produced match the 
observed experimental data very well, as shown in Figures 4, 5 and 6. Median absolute percentage errors 
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are less than 5% for the volumes and less than 7% for the pressures, as shown in Table 1. These errors 
are well within typical experimental measurement errors [23, 24]. 
 
A second important finding of this research is that, despite the reduced data set and necessary 
assumptions made, the CVS model is able to accurately identify and re-simulate endotoxic shock. 
Clinically, and importantly, the identified parameter trends match physiological expectations. For example, 
Figure 7 shows the model simulated normalized systemic volume and how it decreases during the time 
course of the experiment, accounting for the loss of circulatory control and hypovolemia seen in septic 
shock [5, 6]. The data and results obtained from the pig-specific identified models thus match clinical and 
experimental measurements and expectations. 
 
Figure 7 also shows the mean normalized identified trends for the CVS model parameters Rsys, Rpulin and 
Rvr over all analyzed pigs during the experiment. The value of Rsys is perhaps (unexpectedly) identified to 
initially increase at the beginning of the experiment. However, after 30 min and with the ongoing endotoxin 
infusion, Rsys is decreasing, with a further two relatively small increases at the end of the experiment. 
Overall, this trend indicates an initial physiological compensation followed by a failure of circulatory control 
that is typical of septic shock [6]. From a model-based diagnostics perspective, this result accurately 
tracks disease onset, initial (successful) compensation and (eventual) physiologic failure, all of which are 
clinically significant in determining appropriate therapies and dosing. 
 
The mean normalized Rpulin values over all pigs increase during the experiment, as expected [5, 6]. There 
is a sharp drop at 60 mins into the experiment. However, this decrease is consistent with previously 
published results [12], where a similar drop can be observed at 60 min. Clinically, the model is thus 
capturing the known effects of sepsis in this portion of the circulation, as well.  
 
Given the potential clincal use of this model-based monitoring and diagnostic method, it is important to 
note that differences in systemic (Rsys) and pulmonary (Rpulin) behaviours and resistances can help dictate 
the clinical therapeutic balance between vasopressor and fluid resuscitation therapy if they are known. 
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Hence, this model and identification method can provide this level of clinical advice and guidance. Equally 
importantly, it has accomplished this task in this study despite significant inter-pig variation in measured 
data, as well as significant intra-pig variation over time as the induced septic shock evolves and impacts 
cardiovascular system function.  
 
Diagnostically, the mean normalized resistance to venous return, Rvr, decreases consistently during the 
experiment. This result is expected, as the venous return is already impeded by a low blood volume 
caused by fluid losses into the tissue, as well as by the effects of veno- and vasodilation. In septic shock, 
proinflammatory cytokines cause an increase in endothelial-derived nitric oxide, which in turn is a major 
mediator for vasodilation and hypotension [5]. Therefore, the body tries to restore venous return and the 
model identifies this behaviour as a lowered resistance to venous return that is needed to compensate for 
the lower venous volume, pressure and flow back to the heart. Again, this capability to very specifically 
capture the circulatory dysfunction due to sepsis has significant importance in the realms of clinical 
diagnosis and therapeutic decision support required to first identify the dysfunction in a timely fashion and 
to then balance therapy selection and dosing. 
 
The model makes several key assumptions due to the clinically realistic, but otherwise minimal, data set 
utilised. Notably, that the volumes of the left and right ventricles, as well as their stroke volumes, are 
equal. The quality of the results rests on the validity of these assumptions over the cases observed and 
typical behaviours in critical illness.  
 
First, the more critical assumption that the left and right ventricle stroke volumes are equal is axiomatically 
valid in virtually every typical circumstance [25]. The exception to this case is when there is significant, 
measurable intra-cardiac shunt. However, this case occurs very rarely and is due to either an acquired 
condition, such as a septal rupture following an acute myocardial infarction, or because of a congenital 
heart condition. However in those rare circumstances other clinical signs or results of investigations would 
usually identify these conditions a priori. Hence, this assumption is valid and supports the use of only a 
single catheter in the practical, clinical application of this approach. 
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Given this limitation, a comparison can be drawn to prior work [7, 26] that had a more complete data set 
across both ventricles. Although the data sets did not allow direct analysis or comparison (by withdrawing 
measurements and repeating). The median errors for common identified variables can be contrasted. 
Specifically, the errors for [SAP SPAP RVEDV RVESV] = [2.87 3.02 1.37 1.55]% in Table 1, and are [3.09 
7.01 1.18 1.90]% in [7, 26]. Although the experiments were quite different in specifics, the very similar 
values, and median errors below the 8-10% expected of measurement noise across similar numbers of 
pigs indicates that very little has been lost in this reduced data set. What has been lost more specifically, 
is the ability to obtain animal-specific left heart parameters as in [7, 26]. Thus, the main difference is one 
of identifying less parameters, rather than an increase in error. 
 
Second, is the less critical assumption of equality between left and right ventricle volumes. This 
assumption is not always true at a given point in time due either to normal physiological differences in 
cardiac anatomy where the left ventricle is slightly larger, or to specific patient condition such as 
pulmonary embolism. However, its assumption over a given analysis, as presented here, does not detract 
from the results. Importantly, the relatively small (< 15%) differences in volumes that occur merely shift the 
results obtained in identifying the model. However, it is very important to note that the monitoring and 
diagnostic importance of the model lies in the trends obtained for model parameters over the course of a 
disease state and not in the specific values identified. These trends are valid even if the ratio between 
ventricular volumes is different from that assumed. 
 
To test both these issues and assumptions, particularly in humans, would require, in most cases, more 
invasive monitoring than would be justified clinically. In particular, it would require that both sides of the 
heart have an appropriate catheter to assess stroke volume, and further invasive measurements or 
echocardiography to assess ventricular volume. Such trials would be ethically challenging in humans, and 
thus not likely warranted unless these assumptions were seriously questioned by adverse results in 
upcoming human clinical trials. 
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Conclusions 
The extended integral-based parameter identification approach presented successively identified pig-
specific parameters for the extended CVS model using a significantly reduced and clincally relevant set of 
measurements. This further validation study shows the ability of the model to adequately and realistically 
capture the impact of pressure-volume changes during endotoxic shock. Robustness was demonstrated in 
the ability to capture significant intra- and inter- pig variation, while clincial validation was evident in the 
ability of the identified model to capture measurements that were made but not used in the identification 
process. Finally, all results matched the measured (used and unused) experimental data within typical 
measurement errors, as well as capturing all expected physiological and clinically expected trends, 
indicating its clinical suitablility as a real-time diagnostic tool. In particular, the model is able to aggregate 
diverse measured data into a clear, clinically and physiologically relevant diagnostic picture as the 
condition develops, and can do so with a clinically relevant and minimal data set with respect to invasive 
catheters. This research thus increases confidence in the clinical applicability and validity of this overall 
diagnostic monitoring approach preparatory to initial studies with human subjects. 
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Figure Legends 
Figure 1: Extended CVS model overview which includes additional compartments (P,V)sys and (P,V)cap  to 
differentiate the arterial and venous sides of the pulmonary and systemic circulation. 
Figure  2: Parameter identification algorithm: 1.) a set of parameters is used for an initial simulation, 2.) 
data is then scaled to match the measured data and 3.) identified. This process is iterated until the 
simulation output is acceptable.  
Figure  3 (a)-(c): Model output (dotted) vs clinical (solid line) volume and pressure waveform signals for 
right ventricle (RV). The upper panel shows the clinical vs. simulated ventricle and arterial pressure. The 
lower panel shows the clinical vs. simulated ventricle volume. The results are shown for (a) 0, (b) 90 and 
(c) 120 minutes into the experiment. There is no re-scaling of the results, which are the final product of re-
simulating the identified animal-specific model and comparing to the clinical data. 
Figure  4: Clinical (solid line) vs simulated identified animal-specific model (cross) right ventricular stroke 
volume (RVSV) over all analyzed times and pigs.  
Figure  5: Clinical (solid lines) vs simulated systolic (cross) and diastolic (box) arterial pressures (SAP, 
20 
 
DAP) over all times and pigs.  
Figure  6: Clinical (solid lines) vs simulated systolic (cross) and diastolic (box) pulmonary artery pressures 
(SPAP, DPAP) over all times and pigs.  
Figure  7 (a)-(d): Mean normalized values for estimated systemic volume Vsys,eff (a) and the identified 
model parameters systemic vascular resistance Rsys (b), pulmonary vascular resistance Rpulin (c) and 
resistance to venous return Rvr (d) over all analyzed pigs during the septic shock experiment. 
Figure  8: Mean normalized right ventricular end-systolic elastance esrvfE  over all analyzed pigs during 
the septic shock experiment. Upper panel: clincal experimental results as obtained by [12] without the 
model; lower panel: results obtained with CVS model and identification process and clincally relevant 
limited data as presented in this study.  
  
  
  
 
Appendix A: CVS Model Equations 
 
Ventricle volumes and flows: 
 
lvf lv sptVV V−=     (1) 
rvf rv sptVV V= +       (2) 
pcd lv rvVV V= +      (3) 
( )0,
0, ( 1)
V Vpcd pcd pcd
pcd pcdP P e
λ −= −    (4) 
peri pcd thP P P= +      (5) 
av av lv ao av avL Q P Q RP − −=         (6) 
mt mt pu lv mt mtL Q P P Q R= − −         (7) 
pv pv rv pa pv pvL Q P P Q R= − −                                 (8) 
tc tc vc rv tc tcL Q P P Q R= − −                                   (9) 
 
Pressures: 
 
,( )pu pu pu d pu thP E V V P= − +     (10) 
,( )pa pa pa d pa thP E V V P= − +     (11) 
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,( )vc vc vc d vc thP E V V P= − +     (12) 
,( )ao pao ao d aoP E V V= −     (13) 
,( )sys sys sys d sysP E V V= −      (14) 
,( )cap cap cap d capP E V V= −      (15) 
 
 
Volumes: 
 
pv pulout mtV Q Q= −     (16) 
pa pv pulinV Q Q= −     (17) 
vc vr tcV Q Q= −      (18) 
ao av sysV Q Q= −     (19) 
sys sys vrV Q Q= −      (20) 
cap pulin puloutV Q Q= −      (21) 
 
 
Flows: 
 
ao sys
sys
sys
P P
Q
R
−
=     (22) 
sys vc
vr
vr
P P
Q
R
−
=               (23) 
pa cap
pulin
pulin
P P
Q
R
−
=       (24) 
cap pu
pulout
pulout
P P
Q
R
−
=         (25) 
 
Ventricular interaction and septum volume: 
 
lv lvf periP P P= +     (26) 
rv rvf periP P P= +     (27) 
( )0,
, , 0,· · ( ) (1 ) · · ( 1)
V Vlvf lvf lvf
lvf es lvf lvf d lvf lvfP driL E V V driL P e
λ −= − + − −       (28) 
( )0,
, , 0,· · ( ) (1 ) · · ( 1)
V Vrvf rvf rvf
rvf es rvf rvf d rvf rvfP driR E V V driR P e
λ −= − + − −  (29) 
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( ) ( ) ( )
( )( ) ( ) ( )
( )( ) ( )
( )0,
, , 0, ,
( )
0, ,
( )
0,
( ) (1 ( 1) ( )
1 1 ( )
1 1
V Vspt spt spt
es spt spt d spt spt es lvft lv spt
V Vlvft lv spt
lvf es rvft rv spt
V Vrvft rv spt
rvf
e t E V V e t P e e t E V V
e t P e e t E V V
e t P e
λ −
λ −
λ +
− + − − = −
+ − − − +
− − −
(30) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Abbreviations used in the CVS model  
Abbreviation Description 
 λ  parameter in EDPVR 
 P0 parameter in EDPVR 
 lv left ventricle 
 rv rRight ventricle 
 lvf left ventricle free wall 
 rvf right ventricle free wall 
 spt septum 
 pcd pericardium 
 V0 volume at zero pressure 
 Vd unstressed chamber volume 
  R resistance 
  E elastance 
  L inertance 
 P pressure 
 Q flow 
 V volume 
 mt mitral valve 
 tc tricuspid valve 
 av aortic valve 
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 pv pulmonary valve 
 pulin systemic pulmonary 
 pulout venous pulmonary 
 sys systemic 
 cap capillary 
 vr venous return 
 es end-systolic 
 Pth intrathoracic pressure 
 period heart beat period 
 driL Activation (driver) function for LV 
 driR Activation (driver) function for RV 
 driS Activation (driver) function for Septum 
 
 
